Serum Diethyl Phthalate Levels in Infertile Females with Endometriosis

In: Pakistan Journal of Medical and Health Sciences · 2021 · vol. 15(12) , pp. 3214–3217 · doi:10.53350/pjmhs2115123214 · W4200535734
article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-23

This study found significantly higher serum diethyl phthalate (DEP) levels in infertile females with endometriosis compared to fertile controls without the condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-23 · read from full text

This case-control study measured serum diethyl phthalate (DEP) levels in 50 infertile women aged 20–40 years with laparoscopically diagnosed endometriosis and compared them with 50 age-matched controls with proven fertility and negative endometriosis screening. DEP concentrations were quantified in stored serum using high-performance liquid chromatography (HPLC), and participants on any medication (including hormone therapy) or with comorbid conditions were excluded. Endometriosis cases had significantly higher mean serum DEP levels than controls (3.76±1.28 ng/ml vs 2.61±1.72 ng/ml; p=0.003), and DEP increased with endometriosis stage in a non-significant trend. The main limitation explicitly reflected in the design is the cross-sectional case-control snapshot with a relatively small sample and exclusion of medicated/comorbid participants, which may constrain generalizability. This paper is centrally about endometriosis — it specifically assesses whether higher serum diethyl phthalate levels are associated with infertility in women with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis has a complex multifactorial pathophysiology and is a leading cause of female infertility. Emerging evidence suggests the role of endocrine disrupting chemicals and environmental factors such as Diethyl phthalate (DEP) in the pathophysiology of the disease. Aim: To investigate the serum DEP levels in females with infertility having endometriosis and normal healthy counter parts. Methods: Married females (n=50) age 20-40 years, diagnosed with endometriosis and having history of >1 year of infertility, were selected as cases. Age matched women (n=50) with proven fertility and screened negative for endometriosis were included as controls. Females on any medicine, having co morbid conditions were also excluded from the study. DEP concentration in serum was determined by using High performance liquid chromatography (HPLC). Results: Significantly higher levels (p=0.003) of DEP were seen in endometriosis females (3.76± 1.28 ng/ml) as compared to controls (2.61± 1.72 ng/ml). The comparison of DEP levels between different stages of endometriosis revealed an increasing, but no significant trend with advancement of the disease. Conclusion: High serum DEP levels in patients substantiate their role in disease pathophysiology. Therefore, it may be advisable to pay attention while using such compounds. There is an increased need to regulate the levels of such industrial compounds manufactured for daily use of human beings by efficient and judicious quality assurance plastics and by using the standards set by WHO and/or FDA. Keywords: Phthalate, Endometriosis, Diethyl phthalate, plasticizers, Infertility
Full text 22,213 characters · extracted from oa-pdf · 11 sections · click to expand

Abstract

Background: Endometriosis has a complex multifactorial pathophysiology and is a leading cause of female infertility. Emerging evidence suggests the role of endocrine disrupting chemicals and environmental factors such as Diethyl phthalate (DEP) in the pathophysiology of the disease. Aim: To investigate the serum DEP levels in females with infertility having endometriosis and normal healthy counter parts.

Methods

Married females (n=50) age 20 -40 years, diagnosed with endometriosis and having history of >1 year of infertility, were selected as cases. Age matched women (n=50) with proven fertility and screened negative for endometriosis were included as controls. Females on any medicine, having co morbid conditions were also excluded from the study. DEP concentration in serum was determined by using High performance liquid chromatography (HPLC).

Results

Significantly higher levels ( p=0.003) of DEP were seen in endometriosis females (3.76± 1.28 ng/ml) as compared to controls (2.61± 1.72 ng/ml). The comparison of DEP levels between different stages of endometriosis revealed an increasing, but no significant trend with advancement of the disease.

Conclusion

High serum DEP levels in patients substantiate their role in disease pathophysiology. Therefore, it may be advisable to pay attention while using such compounds. There is an increased need to regulate the levels of such industrial compounds manufactured for daily use of human beings by efficient and judicious quality assurance plastics and by using the standards set by WHO and/or FDA.

Keywords

Phthalate, Endometriosis, Diethyl phthalate, plasticizers, Infertility

Introduction

Endometriosis, is disease in which the presence of endometrial tissue in ectopic sites, other than uterine cavity and is one of the commonest causes of female infertility 1. About 15% of peoples in industrialized world is consults for infertility 2. The frequency of the endometriosis in Pakistan reported to 20.2% in cases of primary infertility3 which is consistence with results of other studies of different populations4,5. New evidence propose that possible role of envir onmental contamination of endocrine disrupting chemicals (EDC’s) in the pathophysiology of endometriosis 6. An endocrine disrupting chemical is an exogenous substance that hinder with production, binding, and removal of natural sex hormones 7. Some chemicals stimulate the growth of endometrial cells that play an important role in endometrial angiogenesis 8,9. Among such EDC’s phthalates have attained special focus due to their existence in everyday life products10. Phthalates are esters of Phthalic acid. A class of organic chemicals that are used as plasticizer to increase the pliability of polyvinylchloride (PVC). They are used in immense range of products for example food packaging materials, medical devices, medicines, kids’ toys as well as beauty and personal care brands11. Out of the primary phthalate compounds , diethyl phthalate (DEP) is most frequently used plasticizer globally. Its most common use is in cosmetics, pharmaceutical and food packaging materials12. Once in side the body these phthalates are promptly metabolized to their monoesters after hydrolysis and conju gation, and then excreted in urine, feces and other body secretions. Primary and secondary phthalate metabolites are bio -active13,14. Public and scientific concern is being focused to inquire the role of phthalate exposure in estrogen related disease such as endometriosis. Studies have shown accumulation of these substances in blood, follicular fluid, urine, saliva and sweat of infertile females 15,16,17. So far, fewer reports have been published on the subject and nothing exists from Pakistan. A Few authors reported that there is positive association between phthalate ----------------------------------------------------------------------------------------- Received on 07-06-2021 Accepted on 27-11-2021 exposure and endometriosis 18,19, while others reported contradictions20,21. Pakistan is a country where plastic and plastic related products are very heavily used, particularly by the lower middle class and modest communities. Plastic containers are even used for carrying very hot food items and apart from their industrial use, small factories or cottage industries making plastic utensils and shopping bags use recycled plastic materials, which make these items quite hazardous to t he general health of the public. Also there are women of the reproductive age who work in these home-based factories where there is least concept of quality control, quality assurance and health hazards. Keeping in view of these facts we conducted the present study to understand whether exposure to diethyl phthalate is associa ted with risk of endometriosis.

Material and methods

The case control study was approved by Ethical review board of University. Sample size was calculated by using the following formula: Study population comprised of 50 young (20 -40 years) females laparoscopically diagnosed of endometriosis and had a history of infertility (>1 years). Staging of the disease was done according to ASRM criteria for endometriosis staging 22. A comparable number (n=50) of same age group healthy females who gave birth a child in last two years, also negative for endometriosis screened by ultrasonography followed by detailed clinical evaluation and examination by specialized doctors served as controls. Females on any medication especially hormone treatment, history of infertility other tha n endometri osis or having co -morbid conditions , were excluded from the study. After taking written well informed consent from all study participants, a detailed medical, socioeconomic and occupational history with detailed general physical and systemic clinical evaluation was done by a qualified doctor. Ten milliliters of blood was drawn under aseptic conditions. Serum was separated after centrifugation; and stored in glass vials at -80 ◦C for later analysis. High performance liquid S. Nazir, I. Nazir, R. Khan et al P J M H S Vol. 15, No.12, DEC 2021 3215 chromatography (Perkin Elmer series 200 UV pump) was used to determine diethyl phthalate concentrations. Reagents and solutions preparation : Stock solution of HPLC grade (Merck chemicals, Germany) 99.99% diethyl phthalate (DEP) and its internal standards were prepared in HPLC grade (Fisher scientific, Germany) acetonitrile, and stored at -20˚C to test the linearity. With a DEP concentration of 10, 50, 100, 250, 500, and 1000 ng/ml, Calibrators were prepared in serum. A total of 200 µL of serum was added with 50 µL of internal standard, 400 µL of 1 mol/L NaOH (HPLC grade; Sigma Aldrich, USA), 100 µL of 50 % H3PO4 (HPLC grade; Sigma Aldrich USA) and 600 µL of 50 % acetonitrile (Fisher scientific, Germany). High Performan ce Liquid Chromatography (HPLC): After 10 minutes at 1500 rpm centrifugation , the supernatant was separated, and 10 µL of the supernatant was injected into the HPLC glass vials via syringe filter (25mm/ 0.22 micrometer) , and put in auto- sampler (Perkin Elmer series 200). To avoid potential contamination, all glass vials were clean with methanol, acetone and acetonitril. HPLC was carried out using Perkin Elmer series 200 UV pump, attached to a Diode Array UV/ visible Perkin Elmer series 200 detector. A Perkin Elmer 250 x 4.6 mm (internal diameter) Brownlee analytical C18 (5 -µm particle size) column (USA) was used. Results were analyzed on Total chrome Navigator 3.1.5 software. The mobile phase consisted of a mixture of 1ml/L acetic acid (Sigma Aldrich, USA) in water and 1ml/L acetic acid in acetonitrile (10/90, vol/vol). Elution was performed with the use of an isocratic mode at 0.5 ml/min. Total chromatographic run time was 10 minutes. Peak for DEP was obtained at 6.43 minutes (retention time). Concentration of DEP was calculated by using straight line equation. Statistical analysis : By using IBM -SPSS version 20 , data was analyzed. The variables were analyzed and expressed as Mean(±SD). Two sample Student’s‘t’ test, was applied to compare the phthalate esters concentrations in both cases and controls. A p value of ≤ 0.05 was considered as statistically significant. To compare the levels of DEP between different stages of endometriosis one-way ANOVA was applied.

Results

Individual values for DEP in endometriosis females and controls were calculated by using straight line equation among peak area of standard and concentration of standard, and putting individual peak areas for cases and control in straight line equation, as expressed in fig. 1. Fig. 1: DEP straight line equation according to least square method for calculating values in both cases and controls. Description of chromatographs: Fig. 2a, 2b, 3a and 3b describe DEP chromatographs , obtained through High performance liquid chromatography in cases and controls respectively. The X -axis shows the retention time (minutes), and Y -axis shows milli- Absorbance Units (mAU). Figures 2a and 3a are real time chromatographs, showing the peak of DEP at its respective retention times in cases an d controls respectively. Fig. 2b and 3b , are reprocess results collected from total chrome navigator 3.1.5 software , showing DEP peaks in cases and controls at their respective retention times. Fig. 2a: HPLC Real time chromatograph of cases showing the DEP peak . Generated from: Total chrome navigator; 3.1.5 software. Fig. 2b: HPLC Reprocess Chromatograph of cases showing the DEP peak area. Generated from: Total chrome navigator 3.1.5 software. Figure 3a: Real time chromatograph of HPLC of control showing the DEP peak. Generated from Total chrome navigator (3.1.5 software). Retention time (minutes) Serum Diethyl Phthalate Levels 3216 P J M H S Vol. 15, No.12, DEC 2021 Figure 3b: Reprocess Chromatograph of HPLC of control showing the DEP peak area. Generated from Total chrome navigator (3.1.5 software). Statistically significant difference ( p=0.003) in mean DEP serum concentration of cases (3.76±1.28 ng/ml) and controls (2.61±1.72 ng/ml) was observed (figure 4). Figure 4: Comparison of Means ±SD between cases and controls for DEP statistics according to the “t” test. Based on the points system as per American Society for Reproductive Medicine classification of endometriosis, patients were assigned to one of the four stages and serum DEP levels were compared among all stages. Table 1: Mean ( ±SD DEP) values in all four stages of endometriosis, statistics according to one- way ANOVA. There was an increasing tendency in the M ean values of serum DEP as the stage advances, but the difference was insignificant. The comparison of mean values of demographic factors i.e. age, age at menarche, weight and height did not differ significantly between cases and control groups (Table 2). Table 2: Comparison of Anthropometric factors between cases and controls statistics according to the “t” test.

Discussion

Endometriosis is a gynecological disorder, which is characterized by the existence of ectopic endometrial tissue. Regardless of th e extensive development of endometriosis , the etiology and pathophysiology of the disease is yet to be explicated. Environmental hazardous toxins have previously shown to be associated to endometriosis. The aim of this study was to identify the levels of phthalates, which are comm on endocrine disruptors, in age- matched females with diagnosed endometriosis, as well as healthy females. Pakista n lacks a strict quality control over the use of common plastic compounds such as plastic food wraps, medical devices, beverages containers, and the linings of metal cans. A good number of Pakistani females work in the pharmaceutical industry and an equally good number uses daily cosmetics. Hence, the risk of exposure to phthalates in this region is reasonably higher compared to developed coun tries. Although a variety of phthalate compounds has been studied, we selected DEP which is a parent compound of phthalate, widely distributed and mostly present in plastic, medical devices and daily use products. It enter the body through inhalation, cutaneous contact, and through food and medicine ingestion23. The literature for serum DEP levels in infertile females with endometriosis is sparse. This study is the first report from Pakistan demonstrating the relationship between serum DEP levels and infertility with endometriosis. Our study recruited endometriosis patients diagnosed by laparoscopy. Our results showed significantly higher (p=0.003) serum DEP (diethyl pht halate) levels in females with endometriosis, compared to controls. These results are i n accord with previous study , which shows high DEP levels but detection rate is low in this study (0 -16.4%)24. This difference may be due to more judicial use of DEP products in our country especially hot food packaging in plastic bags and containers and poor quality cosmetic products. These results are contrary to previous studies which show undetectable levels of DEP in both cases and controls 24-27. This difference in results may be due to differences in the techniques, as Reddy et al (2003) used gas chromatography and in Rozati et al (2008) (28) HPLC techniqu e, control and cases criteria was different from ours. DEP used as a solvent and fixative for fragrance , cosmetic ingredients , subsequent contact with skin may lead to high levels of DEP. In order to show correlation between DEP concentrations and severity of the disease, we analyzed the mean DEP values between stages (I, II, III and IV) of endometriosis. This analysis showed no significant diffe rence in mean DEP le vels among the stages of endometriosis. However, there was an increasing trend S. Nazir, I. Nazir, R. Khan et al P J M H S Vol. 15, No.12, DEC 2021 3217 of mean values of DEP with advancement of stage (Table 1). These results were in contrary to previous study24 which showed increase phthalate levels with advancement of disease. We compared the anthropometric parameters , i.e. age at menarche, height, weight and age with serum DEP levels , but no statistical ly significant difference was observed between cases and c ontrols (Table 2). Therefore, no association was ascertained among the anthropometric factors and endometriosis which is in consistency with previous results by Rozati et al28. Our results favor the previous studies showing positive association of Diethyl phthalates with endometriosis. Unfortunately, because of our financial limitations , we could not expand our experiments, which may provide more elaborated understanding about the possible role of these phthalate compounds in the pathophysiology and etiology of endometriosis.

Conclusion

Further studies are necessary to answer the mechanistic pathway through which these compounds alter the normal physiology and lead to disease development. We proposed that future studies should be conducted on c omparison of serum DEP levels in infertile females with endometriosis with infertile females without endometriosis.

References

1. Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, Diagnosis and Clinical Management. Curr Obstet Gynecol Rep. 2017; 6(1):34–41. 2. Reid, R., Steel, A., Wardle, J. et al. The prevalence of self -reported diagnosed endometriosis in the Australian population: results from a nationally-representative survey. BMC Res Notes, 2019; 12, 88. 3. Rao SI, Siddiq S, Qadir SY, Sarfraz Z, Ra na M. Endometriosis; prevalence of endometriosis on laparoscopy in subfertile women. Professional Med J 2019; 26(5):702-706. 4. Al-Jefout, M., Alnawaiseh, N., Yaghi, S., Alqaisi, A., Prevalence of Endometriosis and Its Symptoms among Young Jordanian Women with Chronic Pelvic Pain Refractory to Conventional Therapy. Journal of Obstetrics and Gynaecology Canada, 2018; 40 (2), 165-170. 5. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–99 6. Smarr MM, Kannan K, Buck Louis GM. Endocrine disrupting chemicals and endometriosis. Fertil Steril. 2016 Sep 15;106 (4): 959-66. 7. Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Hauser, R., Prins, G.S., Soto, A.M., 2009. Review: Endocrine -disrupting chemicals: an Endocrine Society Scientific Statement. Endocr. Rev., 30(4): 293-342. 8. Bredhult C, Backlin BM, Olovsson M. Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro. Reprod toxicol 2007, 23:550-9 9. Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, et al. Female reproductive disorders: the roles of endocrine -disrupting compounds and developmental timing. Ferti sterti 2008, 90; 911 -40 10. Witorsch RJ, Thomas JA. Personal care products and endocrine disruption: A critical review of the literature. Crit Rev Toxicol. 2010; 40 Suppl 3:1-30. 11. Pasquale Ventrice, Domenica Ventrice, Emilio Russo, Giovambattista De Sarro. Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity. Environmental Toxicology and Pharmacology. 2013; 36 (1), 88-96. 12. Veiga, Marlei, Bohrer, Denise, Nasciment o, Paulo C., Ramirez, Adrian G., Carvalho, Leandro M., & Binotto, Regina. Migration of phthalate - based plasticizers from PVC and non -PVC containers and medical devices. Journal of the Brazilian Chemical Society, 2012; 23(1), 72-77. 13. Elena Domínguez -Romero, Martin Scheringer. A review of phthalate pharmacokinetics in human and rat: what factors drive phthalate distribution and partitioning? Journal Drug Metabolism Reviews . 2019; 51 (3), 314-329 14. Choi J, Knudsen LE, Mizrak S, Joas A.. Identification of exposur e to environmental chemicals in children and older adults using human biomonitoring data sorted by age: results from a literature review. 2017. Int J Hyg Environ Health. 220:282–298. 15. G. Saravanabhavan, M Walker, M Guay, L Aylward. Urinary excretion and dai ly intake rates of diethyl phthalate in the general Canadian population. Science of the Total Environment . 2014; 500 –501, 191 – 198. 16. Drbohlav, P., Jirsová, S., Masata, J., Jech, L., Bencko, V., Omelka, M., Zvárová, J., 2005. Relationship between the levels of toxic polychlorinated biphenyls in blood and follicular fluid of sterile women. Ceska. Gynekol., 70(5): 377-383. 17. Jing Sun , Bo Chen , Liqian Zhang , Dong Zhao , Shu Guang Li.Phthalate ester concentrations in blood serum, urine and endometrial tissues of Chinese endometriosis patients. Int J Clin Exp Med . 2016; 9(2): 3808-3819 18. Itoh, H., Iwasaki, M., Hanaoka, T., Sasaki, H., Tanaka, T., Tsugane, S., Urinary phthalate monoesters and endometriosis in infertile Japanese women. Sci.Total Enviro., 2009. 408(1): 37-42. 19. Kim, Y.H., Kim, S.H., Lee, H.W., Chae, H.D., Kim, C.H., Kang, B.M., Increasedviability of endometrial cells by in vitro treatment with di - (2ethylhexyl) phthalate. Fertil. Steril., 2010. 94(6): 2413 -2416. 20. Pauwels, A., Schepens, P.J., D'Hoo ghe, T., Delbeke, L., Dhont, M., Brouwer, A., Weyler, J., 2001. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case -control study of infertile women. Hum. Reprod., 16: 2050-2055. 21. Blount BC, Silva MJ, Caudill SP, et al. (2000). Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect, 108, 979–82 22. Neil P Johnson, Lone Hummelshoj, G David Adamson, Jörg Keckstein, Hugh S Taylor, Mauricio S Abrao, Deborah Bush, Ludwig Kiesel, Rulla Tamimi, Kathy L Sharpe -Timms, Luk Rombauts, Linda C Giudice, World Endometriosis Society Sao Paulo Consortium, World Endometriosis Society consensus on the classification of endometriosis, Human Reproduction, 2017; 32(2), 315–324, 23. National Research Coun cil (US) Committee on the Health Risks of Phthalates. Phthalates and Cumulative Risk Assessment: The Tasks Ahead. Washington (DC): National Academies Press (US); 2008. 2, Phthalate Exposure Assessment in Humans. Available from: https://www.ncbi.nlm.nih.gov/books/NBK215044/ 24. Reddy, B.S., Rozati, R., Reddy, B.V., Raman, N.V., 2006a. Association of phthalate esters with endometriosis in Indian women. B.J.O.G., 113: 515–520. 25. Cobellis, L., Latini, G., DeFelice, C., Razzi, S., Paris, I., Ruggieri, F., Mazzeo, P., Petraglia, F., 2003. High plasma concentrations of di -(2- ethylhexyl)-phthalate in women with endometriosis. Human Reprod., 18:1512-1515. 26. Gerhard, I.; Daniel, V., Link, S., Monga, B., Runnebaum, B., 1998. Chlorinated hydrocarbons in women with repeated misc arriages. Environ. Health Perspect., 106(10): 675-681. 27. Itoh, H., Iwasaki, M., Hanaoka, T., Sasaki, H., Tanaka, T., Tsugane, S., 2009. Urinary phthalate monoesters and endometriosis in infertile Japanese women. Sci.TotalEnviro., 408(1): 37-42. 28. Rozati, R., Simha, B., Bendi, N., Sekhar, C., 2008. Evaluation of the Phthalate Esters in South Indian Women with Endometriosis. I. J. F. S., 1(4): 165-170.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK